Clinical Trials Browser

Carcinoma, Transitional Cell × toripalimab × 1 year × Clear all

NCT07314723 2026-01-02

9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer

Phase 2 Recruiting

Carcinoma, Transitional Cell

NCT07189793 2025-09-24

OHAI-NMIBC-01

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT06823427 2025-03-21

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2 Recruiting

Carcinoma, Transitional Cell